Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms- |
Target- |
Action- |
Mechanism Proteolysis |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC58H82N8O14S2 |
InChIKeyWGJCHHJGGFCCRS-DEYDLUNASA-N |
CAS Registry2244684-49-7 |





